Ranevetmab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Rat |
Target | nerve growth factor |
Clinical data | |
Synonyms | NV-01 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6496H10022N1756O2052S48 |
Molar mass | 147.1 g/mol |
Ranevetmab (NV-01) (INN[1]) is a veterinary monoclonal antibody designed for the treatment of pain associated with osteoarthritis in dogs.
This drug was developed by Nexvet Australia.[2]
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.